Estimated reading time: seven (7) minutes
US/Silver Spring: WS Global, Inc., a Brooklyn, New York establishment, recalls all current batch/lots of Himalayan Pain Relief Tea Packets from the American marketplace due to suspected undeclared drugs, specifically Diclofenac, an NSAID, and Dexamethasone, a corticosteroid, with consequential risks of a wide variety of severe illnesses and/or possible life-changing complications, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-altering injury or death.
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Nutritional Supplement products are subject to this recall:
Filed under: Dietary Supplements, Drugs, Labeling or regulatory issues, Medical / Veterinary, Sildenafil, US FDA | Tagged: cardiac injury hazard, Dexamethasone contamination, Diclofenac contamination, Dietary Supplements, drug, Himalayan Pain Relief Tea Packets, nutritional supplement, Recalls Direct RIN: 17907-2023, supplement, suspected Stroke hazard, US FDA, US Food and Drug Administration | Leave a comment »